Our lead article this month is dedicated to the annual Foundation for Reproductive Medicine Conference (FRMC), which CHR for the third year in a row proudly co-sponsors here in New York City. Likely because in comparison to most other U.S. cities the organization of conferences in NYC is much costlier, FRMC is now the only international annual event in the city in the areas of reproductive medicine and biology, this year again presenting over 30 speakers from all over the world. For the first time this year, however, the conference also offers on Sunday afternoon, November 18, a half day of lectures and comments from some of the leading experts in infertility, specifically directed at patients. This "Clinical Fertility Day for the Public" includes an interactive Q&A session with the experts on panel. If successful, the plan is to make this Clinical Fertility Day for the Public a steady feature of the conference because, as we will discuss in our lead article, the ultimate goal of this annual conference is the betterment of clinical care in reproductive medicine.
In this issue of the CHR VOICE, we cover:
Read the November 2018 CHR VOICE in PDF.
Norbert Gleicher, MD, leads CHR’s clinical and research efforts as Medical Director and Chief Scientist. A world-renowned specialist in reproductive endocrinology, Dr. Gleicher has published hundreds of peer-reviewed papers and lectured globally while keeping an active clinical career focused on ovarian aging, immunological issues and other difficult cases of infertility.
DISCOVER YOUR TREATMENT OPTIONS
